Petros Giannikopoulos

Petros Giannikopoulos is the Director of the IGI Clinical Laboratory and an Assistant Adjunct Professor of Laboratory Medicine at UCSF. His research in the IGI Clinical Laboratory, a CLIA-certified laboratory that is accredited by the College of American Pathologists to perform high-complexity molecular testing, focuses on the development and deployment of companion diagnostics for novel CRISPR-based genomic therapies, and developing innovative tools and infrastructure to support the growing field of interventional genomics.

Petros is board-certified in anatomic, pediatric, and molecular genetic pathology, and a Fellow of the College of American Pathologists. Before joining the IGI, he was a health technology entrepreneur and also served as Laboratory Director for multiple next-generation sequencing (NGS)-based clinical genomics labs in the US and in Asia. He obtained his MD from Harvard Medical School, completed his pathology residency at the University of California, San Francisco, and trained in pediatric and molecular pathology at Texas Children’s Hospital and Harvard Medical School, respectively.